These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Accelerated thrombolysis by liposomal-encapsulated urokinase in a canine model of acute myocardial infarction].
    Author: Li ZL, Zhang NZ, Nie YH.
    Journal: Zhonghua Yi Xue Za Zhi; 1994 Jun; 74(6):338-40, 389. PubMed ID: 7994640.
    Abstract:
    We prepared liposomal-encapsulated urokinases (LEUK) by detergent removal technique. The encapsulated efficiency of urokinase (UK) was 25.6%. The LEUKs were neutral large unilamellar vesicles and its average diameter was 60.4 +/- 13.6 nm under electron microscope. Measurements of UK activity indicated about 7.1% loss of activity or leakage in tris-buffered saline over a 48 hr period at a temperature of 4 degrees C. After the same time incubation of LEUK and UK in human platelet-poor plasma (PPP) at 37 degrees C, the percentage of UK activity in LEUK group was remaining higher than that of UK group (30 min: 84.3 +/- 3.0% to 46 +/- 4%; 60 min: 60 +/- 5% to 14.9 +/- 0.8%, P < 0.01). These results suggest that liposomes preserve the thrombolytic potential of UK and that the half-life of UK in liposomes prolongs more than two times. Canine model of acute myocardial infarction was based on a thrombos obstruction. Thrombolysis tests were compared for LEUK and UK (n = 5). The time for restoring vessel patency reduced more than 50% when compared with that in UK group (28 +/- 7 min to 69 +/- 7 min, P < 0.01). The total dosage of LEUK was correspondingly lower. After one-hour thrombolysis, the fibrinogen of LEUK group (g/L) was considerably higher than that of UK group (2.5 +/- 0.5 to 1.6 +/- 0.4, P < 0.01). These results suggested that LEUK may be of practical significance in accelerating thrombolysis and reduction in bleeding complications.
    [Abstract] [Full Text] [Related] [New Search]